Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis.
Identifieur interne : 00B430 ( Ncbi/Merge ); précédent : 00B429; suivant : 00B431Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis.
Auteurs : J P Moulia-Pelat ; P. Glaziou ; L N Nguyen ; S. Chanteau ; R. Plichart ; I. Beylier ; P M Martin ; J L CartelSource :
- Transactions of the Royal Society of Tropical Medicine and Hygiene [ 0035-9203 ]
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Calendrier d'administration des médicaments, Facteurs temps, Filariose lymphatique (traitement médicamenteux), Humains, Ivermectine (administration et posologie), Ivermectine (usage thérapeutique), Porteur sain (traitement médicamenteux), Récidive, Wuchereria bancrofti.
- MESH :
- administration et posologie : Ivermectine.
- traitement médicamenteux : Filariose lymphatique, Porteur sain.
- usage thérapeutique : Ivermectine.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Calendrier d'administration des médicaments, Facteurs temps, Humains, Récidive, Wuchereria bancrofti.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Ivermectin.
- drug therapy : Carrier State, Elephantiasis, Filarial.
- chemical , therapeutic use : Ivermectin.
- Adolescent, Adult, Animals, Drug Administration Schedule, Humans, Middle Aged, Recurrence, Time Factors, Wuchereria bancrofti.
Abstract
Forty-three Wuchereria bancrofti carriers were given 4 successive semi-annual single doses of ivermectin 100 micrograms/kg (IVER 100). The geometric mean microfilaremia (mf) recurrence percentages, compared to the pre-initial treatment mf level, were 35%, 21%, 17% and 17% at 6, 12, 18 and 24 months respectively. However, the recurrence of mf 6 months after the fourth treatment remained high in 15 individuals, considered as 'bad responders'. At month 24, the subjects were randomly allocated into 2 groups: the first group was treated with a fifth dose of IVER 100 and the second with a first, single dose of 400 micrograms/kg of ivermectin (IVER 400). At month 30, the mf recurrence percentage was significantly higher in patients treated with IVER 100 than in those receiving IVER 400 (61% vs. 8%, P < 0.05). In the IVER 100 group, 6 of the 8 'bad responders' remained 'bad responders', whereas only 2 of 7 did so in the IVER 400 group. Only 3 additional patients in the IVER 100 group became consistently amicrofilaraemic, whereas 9 did so in the IVER 400 group. Two 'good responders' in the IVER 100 group became 'bad responders'. A single dose of 400 micrograms/kg of ivermectin has been demonstrated to be efficient for the treatment of carriers refractory to repeated doses of 100 micrograms/kg and to result in better long-term mf suppression. These results suggest a possible effect of 400 micrograms/kg of ivermectin on macrofilaria.
PubMed: 8153984
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 005609
- to stream PubMed, to step Curation: 005609
- to stream PubMed, to step Checkpoint: 005609
Links to Exploration step
pubmed:8153984Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis.</title>
<author><name sortKey="Moulia Pelat, J P" sort="Moulia Pelat, J P" uniqKey="Moulia Pelat J" first="J P" last="Moulia-Pelat">J P Moulia-Pelat</name>
<affiliation><nlm:affiliation>Institut Territorial de Recherches Médicales Louis Malardé, B.P., Tahiti, Polynése Française.</nlm:affiliation>
<wicri:noCountry code="subField">Polynése Française</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Glaziou, P" sort="Glaziou, P" uniqKey="Glaziou P" first="P" last="Glaziou">P. Glaziou</name>
</author>
<author><name sortKey="Nguyen, L N" sort="Nguyen, L N" uniqKey="Nguyen L" first="L N" last="Nguyen">L N Nguyen</name>
</author>
<author><name sortKey="Chanteau, S" sort="Chanteau, S" uniqKey="Chanteau S" first="S" last="Chanteau">S. Chanteau</name>
</author>
<author><name sortKey="Plichart, R" sort="Plichart, R" uniqKey="Plichart R" first="R" last="Plichart">R. Plichart</name>
</author>
<author><name sortKey="Beylier, I" sort="Beylier, I" uniqKey="Beylier I" first="I" last="Beylier">I. Beylier</name>
</author>
<author><name sortKey="Martin, P M" sort="Martin, P M" uniqKey="Martin P" first="P M" last="Martin">P M Martin</name>
</author>
<author><name sortKey="Cartel, J L" sort="Cartel, J L" uniqKey="Cartel J" first="J L" last="Cartel">J L Cartel</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>1994 Jan-Feb</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:8153984</idno>
<idno type="pmid">8153984</idno>
<idno type="wicri:Area/PubMed/Corpus">005609</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005609</idno>
<idno type="wicri:Area/PubMed/Curation">005609</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005609</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005609</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005609</idno>
<idno type="wicri:Area/Ncbi/Merge">00B430</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis.</title>
<author><name sortKey="Moulia Pelat, J P" sort="Moulia Pelat, J P" uniqKey="Moulia Pelat J" first="J P" last="Moulia-Pelat">J P Moulia-Pelat</name>
<affiliation><nlm:affiliation>Institut Territorial de Recherches Médicales Louis Malardé, B.P., Tahiti, Polynése Française.</nlm:affiliation>
<wicri:noCountry code="subField">Polynése Française</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Glaziou, P" sort="Glaziou, P" uniqKey="Glaziou P" first="P" last="Glaziou">P. Glaziou</name>
</author>
<author><name sortKey="Nguyen, L N" sort="Nguyen, L N" uniqKey="Nguyen L" first="L N" last="Nguyen">L N Nguyen</name>
</author>
<author><name sortKey="Chanteau, S" sort="Chanteau, S" uniqKey="Chanteau S" first="S" last="Chanteau">S. Chanteau</name>
</author>
<author><name sortKey="Plichart, R" sort="Plichart, R" uniqKey="Plichart R" first="R" last="Plichart">R. Plichart</name>
</author>
<author><name sortKey="Beylier, I" sort="Beylier, I" uniqKey="Beylier I" first="I" last="Beylier">I. Beylier</name>
</author>
<author><name sortKey="Martin, P M" sort="Martin, P M" uniqKey="Martin P" first="P M" last="Martin">P M Martin</name>
</author>
<author><name sortKey="Cartel, J L" sort="Cartel, J L" uniqKey="Cartel J" first="J L" last="Cartel">J L Cartel</name>
</author>
</analytic>
<series><title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title>
<idno type="ISSN">0035-9203</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Animals</term>
<term>Carrier State (drug therapy)</term>
<term>Drug Administration Schedule</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Humans</term>
<term>Ivermectin (administration & dosage)</term>
<term>Ivermectin (therapeutic use)</term>
<term>Middle Aged</term>
<term>Recurrence</term>
<term>Time Factors</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Calendrier d'administration des médicaments</term>
<term>Facteurs temps</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Ivermectine (administration et posologie)</term>
<term>Ivermectine (usage thérapeutique)</term>
<term>Porteur sain (traitement médicamenteux)</term>
<term>Récidive</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carrier State</term>
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Porteur sain</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Animals</term>
<term>Drug Administration Schedule</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Recurrence</term>
<term>Time Factors</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Calendrier d'administration des médicaments</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Récidive</term>
<term>Wuchereria bancrofti</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Forty-three Wuchereria bancrofti carriers were given 4 successive semi-annual single doses of ivermectin 100 micrograms/kg (IVER 100). The geometric mean microfilaremia (mf) recurrence percentages, compared to the pre-initial treatment mf level, were 35%, 21%, 17% and 17% at 6, 12, 18 and 24 months respectively. However, the recurrence of mf 6 months after the fourth treatment remained high in 15 individuals, considered as 'bad responders'. At month 24, the subjects were randomly allocated into 2 groups: the first group was treated with a fifth dose of IVER 100 and the second with a first, single dose of 400 micrograms/kg of ivermectin (IVER 400). At month 30, the mf recurrence percentage was significantly higher in patients treated with IVER 100 than in those receiving IVER 400 (61% vs. 8%, P < 0.05). In the IVER 100 group, 6 of the 8 'bad responders' remained 'bad responders', whereas only 2 of 7 did so in the IVER 400 group. Only 3 additional patients in the IVER 100 group became consistently amicrofilaraemic, whereas 9 did so in the IVER 400 group. Two 'good responders' in the IVER 100 group became 'bad responders'. A single dose of 400 micrograms/kg of ivermectin has been demonstrated to be efficient for the treatment of carriers refractory to repeated doses of 100 micrograms/kg and to result in better long-term mf suppression. These results suggest a possible effect of 400 micrograms/kg of ivermectin on macrofilaria.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8153984</PMID>
<DateCreated><Year>1994</Year>
<Month>05</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>1994</Year>
<Month>05</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0035-9203</ISSN>
<JournalIssue CitedMedium="Print"><Volume>88</Volume>
<Issue>1</Issue>
<PubDate><MedlineDate>1994 Jan-Feb</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Transactions of the Royal Society of Tropical Medicine and Hygiene</Title>
<ISOAbbreviation>Trans. R. Soc. Trop. Med. Hyg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis.</ArticleTitle>
<Pagination><MedlinePgn>107-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Forty-three Wuchereria bancrofti carriers were given 4 successive semi-annual single doses of ivermectin 100 micrograms/kg (IVER 100). The geometric mean microfilaremia (mf) recurrence percentages, compared to the pre-initial treatment mf level, were 35%, 21%, 17% and 17% at 6, 12, 18 and 24 months respectively. However, the recurrence of mf 6 months after the fourth treatment remained high in 15 individuals, considered as 'bad responders'. At month 24, the subjects were randomly allocated into 2 groups: the first group was treated with a fifth dose of IVER 100 and the second with a first, single dose of 400 micrograms/kg of ivermectin (IVER 400). At month 30, the mf recurrence percentage was significantly higher in patients treated with IVER 100 than in those receiving IVER 400 (61% vs. 8%, P < 0.05). In the IVER 100 group, 6 of the 8 'bad responders' remained 'bad responders', whereas only 2 of 7 did so in the IVER 400 group. Only 3 additional patients in the IVER 100 group became consistently amicrofilaraemic, whereas 9 did so in the IVER 400 group. Two 'good responders' in the IVER 100 group became 'bad responders'. A single dose of 400 micrograms/kg of ivermectin has been demonstrated to be efficient for the treatment of carriers refractory to repeated doses of 100 micrograms/kg and to result in better long-term mf suppression. These results suggest a possible effect of 400 micrograms/kg of ivermectin on macrofilaria.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moulia-Pelat</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Institut Territorial de Recherches Médicales Louis Malardé, B.P., Tahiti, Polynése Française.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Glaziou</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nguyen</LastName>
<ForeName>L N</ForeName>
<Initials>LN</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chanteau</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Plichart</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Beylier</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y"><LastName>Martin</LastName>
<ForeName>P M</ForeName>
<Initials>PM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cartel</LastName>
<ForeName>J L</ForeName>
<Initials>JL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Trans R Soc Trop Med Hyg</MedlineTA>
<NlmUniqueID>7506129</NlmUniqueID>
<ISSNLinking>0035-9203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>70288-86-7</RegistryNumber>
<NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002353" MajorTopicYN="N">Carrier State</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014958" MajorTopicYN="Y">Wuchereria bancrofti</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">8153984</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Beylier, I" sort="Beylier, I" uniqKey="Beylier I" first="I" last="Beylier">I. Beylier</name>
<name sortKey="Cartel, J L" sort="Cartel, J L" uniqKey="Cartel J" first="J L" last="Cartel">J L Cartel</name>
<name sortKey="Chanteau, S" sort="Chanteau, S" uniqKey="Chanteau S" first="S" last="Chanteau">S. Chanteau</name>
<name sortKey="Glaziou, P" sort="Glaziou, P" uniqKey="Glaziou P" first="P" last="Glaziou">P. Glaziou</name>
<name sortKey="Martin, P M" sort="Martin, P M" uniqKey="Martin P" first="P M" last="Martin">P M Martin</name>
<name sortKey="Moulia Pelat, J P" sort="Moulia Pelat, J P" uniqKey="Moulia Pelat J" first="J P" last="Moulia-Pelat">J P Moulia-Pelat</name>
<name sortKey="Nguyen, L N" sort="Nguyen, L N" uniqKey="Nguyen L" first="L N" last="Nguyen">L N Nguyen</name>
<name sortKey="Plichart, R" sort="Plichart, R" uniqKey="Plichart R" first="R" last="Plichart">R. Plichart</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 00B430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:8153984 |texte= Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:8153984" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |